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Lack of Prognostic Value of Syncope in Patients With Wolff
Parkinson-White Syndrome
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Syncope in patients with W'olff .Parkinsnn
.White syndrome may
he considered a premonitory event heralding the Mare develop .
meat or sudden death. Therefore, the clinical and electmphysia ,
logic data of 101 patients with Wolff-Park€nse-While syndrome
referred for invasive evaluation of known arrhythmias were
reviewed to assess the incidence and clinical relevance of syncope .
Thirtysis patients reported the occurrence of one or more
syacopal episodes Irroup 1) and 65 patients had no syncope (group
2)
. These two groups did not differ significantly with regard to
age, gender, iacidene and characteristics ofarrhythmia, clinical
history, frequency of arrhythmic events and presence of associ-
ated cardiac disease. There were 10 patients in group I and 12 In
group 2 who had ventricular fihriilatim
.
I here were no statistical differences between the Iwo groups
with respect to the effetive
refractory
period of the right atrium,
atrioventricular node, accessory pathway and right ventricle .
Furthermore, no differences between the Iwo groups were noted
with respect to cycle length of circus movement lachycarSa, mean
hurt rate during Initial hbriliatlm, and minimum OR Interval
Patients with the Wolff.Paricir,an.White syndrome fre-
quently experience palpitation . chest pain at dy.sprlea result-
ing from paroxysmal tachyarrhythmias (II. Syncope is a
less-often described symptom but its occurrence is regarded
as an alarming event 12,3) . In fact, syncope suggests the
occurrence of rapid tachyarrhythmias and the possibility
that they might result in sudden death unless effectively
managed
. In this respect the syncope occurrence in patients
with Wolff-Parkinson-White syndrome could he considered
a warning even] . Therefore, any patient who has experi-
enced this symprom should be promptly and thoroughly
evaluated and managed mate aggressively (3)
.
However, to
date the reason for syncope occurring in patients with
Wolff-Parkinson-White syndrome is not clear and previous
studies (4-8) have yielded no unusual eiectrophysioiogic
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during atrial fibrillation . In addition, the accessory pathway
locallon was not slgniframly differed between group I and group
L
The occurrence of syncope could not be predicted from my
electrophyslologk finding and Ibis symptom Fad a low sensitivity
and specificity for recogddon of dangerous rapid heart rates .
Furthermore, the prognostic value of syncope was less accurate
and predictive than the shortest RR interval during atrial fibril-
lation and the anterograde effective refractory period of the
accessory pathway for aborted sadden death occurrence,
These data show that syncope is a relatively common clinical
finding in patients with Wolff-Parkinsem-White syndrome ire-
fund fee eleclraphystalogie sending and Its occurrence does oat
Identify patients with a risk for sudden death . Furthermore, there
fs no etectrophyslologic variable that could account for syncope
occurrence suggesting that other factors may play a role in the
genesis of this event in symptomatic patents with Wolff-
Parklnsan-White syndrome
.
(J Am Call Candid 1091;17.452-g)
findings in such patients . Also, the clinical relevance and the
incidence of syncope in patients with Wolff-Parkinson-White
syndrome are still a matter ofdebate (4 .6.00) and the predic-
tion olsyncope in such patients by eiectrophysiologic testing
has been assessed only to a minimal relent (R). Furthermore,
the sensitivity and specificity of syncope alone and in
comparison with other high-risk markers for identifying
patients at disk for sudden death have riot been evaluated .
The purpose of this retrospective study was to determine
the incidence of syncope in a population of symptomatic
patients with Wotff-Parkinson-White syndrome referred for
medical or nonpharmacologic treatment and to compare the
eiectrophysiologic findings of patients with a history of
syncop al episodes with those
of patients without syncope. In
addition, this study was designed to define the predictability
of the occurrence of syncope by elictrophysiologic variables
and to define the sensitivity and the specificity of syncope as
a risk factor far sudden cardiac death in the event of atrial
fibrillation. Finally, this study compares the additional prog-
nostic value of the symptom "syncope" in patients with
Wolff-Parkinson-White syndrome and atrial fibrillation dem-
onsirating a short RR interval 4250 ms and in patients with
an artterogmde effective refractory period of the accessory
W)5-107'91s a.: u
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pathway <270 ms as the accepted reference standard in
determining the risk for sudden death in these patients
(9-12) .
Methods
Study patients. One hundred one consecutive patients (66
male . 35 female) with a mean age of 35 years (range 3 .3 1o65)
with Wolff-Parkinson-White syndrome were consecutively
included in the study . Syncope was defined as a sudden
transient loss of consciousness with an inability to maintain
postural tone . There were 36 patients )3hc) who reported at
least one episode of syncope (group 1) and 65 patients i64% j
without a history of syncope (group 2) . Twenty-two patients
(22%) presented an episode of cardiac arrest, most likely due
to atrial fibrillation degenerating into ventricular fibrillation .
This arrhythmic event was considered as an aborted sudden
death because of the prompt and successful management of
the tachyarrhythmia .
Patients with sick sinus syndrome . right or left ventricular
dysplasia, or both, or coronary artery disease were ex-
eluded, Medical history . physical examination. C-lead elm
trocardiogram (ECO), echocardiogram . 24-h ambulatory
ECG recording and a symptom-limited graded treadmill or
bicycle exercise test (modified Bruce protocol) were per-
formed in all patients. Cardiac catheterization was carried
out, if warranted, for associated cardiac lesions or if the
patient was a potential candidate for surgical ablation of the
accessory pathway . A neurologic assessment was obtained
in all patients experiencing syncope .
Electrophysiologic testing . The study was performed in
the nonsedated, postabsorptive state after informed consent
was obtained in writing . All antiarrhythmic drugs were
discontinued at least five drug half-lives before study . 7 wo
bipolar catheters and one quadripolar catheter were intro-
duced transverously and positioned in the high tight atrium .
right ventricular apex and coronary si respectively . A
tripolar catheter was placed across the tricuspid valve for
His bundle recording. The (?lead surface ECG was re-
corded simultaneously with intracardiac signals on a 16-
channel recorder (Mingograf. Siemens) a1 a paper speed
between 100 and 200 mm/s . Programmed .stimulation was
performed according to standard technique (131 using a
stimulator capable of delivering squarc-wave stimuli at twice
diastoli-- threshold . The effective refractory period was
measured after an N-beat drive at a basic cycle length of 600
or 500 ms.
The presence and lo(arion "fan ac, 'rson parlnrrnv' as
well as the mechanism of tachycardias observed, were
determined by criteria previously described (3 .141 . Acces-
sory pathway location was exactly assessed in B'_ patients
undergoing surgical ablation of the accessory pathway . The
accessory pathway location was rcslricted to four main
areas: left, septal . right and multiple . The left and right areas
included accessory pathways located laterally and posteri-
orly and the septal area included parasepialand posterosep-
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tat accessory pathways. The so-called multiple area col-
lected all accessory pathways located at different sites
unrelated to the actual position.
An anrerograde effective refrarrorr period of the acces-
sory pmfnray of <270 ms and a shortest RR interval between
two consecutive pee-excited QRS complexes during atrial
fibrillation of -250 ms were considered variables of higher
risk for sudden death according to previous studies (1h-12) .
Statistical analysis, All variables measured are reported
as mea • values
-
SD . Statistical analysis of data was
performed using the unpaired Student's t test . chi-square
test and Pearson correlation lest . when appropriate
. A p
value <0.05 was considered significant .
Results
Patient ctraracrertstks (Table
1]-
No patients enrolled in
this study suf€ered front a neurologic disease that could
explain the syncopal event and the majority of patient, who
had ,;
cnctpe reported palpitation or chest discomfort before
the syncope .
The distribarion of the conduction modality via the ar-
censon pathway was not statistically significant between the
groups tTahle 1) . Similarly, no statistical difference in EC(;-
documented arrhythmic symptoms was noted between the
two groups and there was no relation between the syncopal
episode and an arrhythmic event.
Fitit incidence of mrhyth core creams was similar in the two
cramps (Tainte I). However, from these
calcularione two
patients of group I and three of group 2 were excluded
because they had a high monthly incidence of reciprocating
tachycardia which would distort the whole group analysis .
Sfos r po rienrs had a hisrorv of rnrhodrnmic reciprocating
rurlnrurdia . that is, 25 patients of group I (6P906) and 52
patients of group 2
(110%
. p = 1,15)
. and in 3 patients of group
I If/iI and in 2 patients of group 2 (3%) an antieromic
reeipnxating atom] Iachycardia occurred (p = NS).
The heart rate during spontaneous episodes of rarkyear-
dia heftrr .vrtds, the mean average RR interval during
documented episodes of atrial fibrillation and the minimal
kit interval between two maximally pre-excited QRS com-
plexes during atrial fibrillation were similar in the two groups
ITahle I1. In eight patients experiencing syncope (Table D. it
was possible to record an ECU during the syncopal episode
demonstrating atrial fibrillation in five and orthodromic
reciprocating tachycardia in the other three patients. The
mean cycle length ofthe curml reeipaoenting tachycardia was
329 ms and the mean shortest RR imertal between two
consecutive pre-exceed beats was 252 ms
.
Antiarrhythmic therapy cmpioycd to suppress known or
suspected arrhythmias in the majority of patien',, before
referral was not statistically significantly different (Table I1
.
However, quantitative information regarding drug dosage at
the time of syncope could not be obtained .
Associated cardiac diseases. The most common cardiac
diseases associated with the Wclff-Parkinson-White syn-
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Table I. Clinical Characmristics of 101 Patients
None
of
the differences between groups are statistically significant . A
fib = a trial fibrillation ; MVP - mitre) valva prolap,n ; RT = raviprosaong
alAsl tachycerdia : VF = vchmcalar fibrillation ; VT = ventricular lachycap
dia.
drome, identified according to the Feigenbaum echocardio-
graphic criteria (15), were manifest or forma fruste Ebstein's
anomaly (4%),
mitral valve prolapse (16%). tricuspid valve
prolapse (2%) and oslium secundum atria) septa) defect
(1%) . There was no difference in the incidence of these
diseases in the two patient groups with or without syncope ;
furthermore, the syncopal episode o5currence was unrelated
to any of these cardiac diseases (r = 0 .35, p = NS)
.
Table 2.
.Arrhyrhmia Profile of the Fight Patients With an EM-Documented History of Syncope
JACC V.I. 17, Na I
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Eketrophysiologk variables (Table 3) . No patient en-
rolled in this study presented a PA or AH interval duration,
or both, out of the normal range
. The effective refractory
period of the right atrium, left atrium (assessed through the
coronary sinus), AV node and right ventricle demonstrated
no significant difference between the two groups
. The acces-
sory pathway refractoriness, evaluated in the anterograde as
well as in the retrograde direction, did not distinguish
patients with syncope from those without . A comparable
number of patients had an anterograde effective refractory
period of the accessory pathway <270 ms . Exact determi-
nations were obtained in 24 patients of group 1 (67%) and in
40 patients of group 2 (62%) . In the remaining patients only
estimated values were assigned where atria) refractoriness
was reached before the effective refractory period of the
accessory pathway . Furthermore, considerable similarity of
both groups was found in the percentage of patients demon-
strating a shortest RR interval during atrial fibrillation of
25250 me.
The cycle length during spontaneous episodes of recipro-
caring eachycardia before this study was very similar to that
attained during tachycardia induced in the laboratory (Fig .
it, Furthermore, the cycle length of the reciprocating taehy-
cardia induced during electrophysiologic testing was compa-
rable in group I and group 2 (Table 3).
A
good correlation behveen spontaneous episodes of
atria) fibrillation
and those induced during electrophysio-
logic study was found with respect to the mean heart rate
(Fig
. 2) and the minimum RR interval between two maxi-
mally pre-excited QRS complexes (Fig
. 3) . There was a
considerable overlap in the average RR intervals during
atria) fibrillation (Table 3), as well as in the shortest RR
interval between two maximally pre-excited QRS complexes
during the atrial fibrillation
. In addition, considerable agree-
ment was found between the groups in the percentage of
patients demonstrating a shortest RR interval of x250 ms
during atrial fibrillation .
The Hro groups could not he distinguished on the basis of
accessory pathway location . In fact, a left-sided accessory
pathway was present in 61% of patients of group I and in
65% of patients of group 2 and a right-sided connection in
AP accessory pathway: ECG - cllnieally docamnnred : EPS electrophysiologic study
. Other abbreviations as in Table 1.
Patient Gender
Age
(yr)
ECG-Arrhylhmia EPSArrhythmia
AP LocationRT(ms) A (b (oat RT(ms) hob trust
1 M 25 240
353 200 Leftlmmal
M 34 553 - 375
r'n Lett lateral
3
F 48 - 280 -
: .-q posterior
4 M 36
- 200 333 196
-ft funeral + seplnt
5 M 58 -
280 316 320 Right anterior
6
F 25 353 353 270 Isn lateral
7 F
29 - 290 316 250
Lea posteroseplal
s M
47
ago -
210 Left lateral
Group I
(n = 36)
Group 2
(n
= 651
Age (yr)
Mean 35 3 16 34 *_ IS
Range 3-60 9-60
Gender
Men 24(67%) 43(667,)
Women 12037H 22 (347)
Conduction -r he accessory pathway
Manifest
321897,) (0(9213)
Inlenniltcnt 11371
10%)
Concealed 3187)
2 (3 1)l
History of tachyan hylhmias
RT 12(337) 23135%)
A fib
8(127)
11(17%1
RT and A fib 16 (4413) 31 (47%
)
VT-VF (cardiacarresq 10128%) 12 (16%)
Incidence orarrhyrhrri- steno
(eventslmnnth)
RT 2,7
5
A fib
0.6
0
.7
Heart rate during arrhythmia
RT (bemslmin) 188 a 35 186 ' 22
Average an interval A fib Ims) 364 x 49 370 0 76
Shortest RR Interval A nb fins) 245 0 40 250
'
44
No
. of
drags
by history 2.4 2 .3
Assneimed cardiac anomalies
Ebstein's anomaly 301%)
H25h
MVP 7119131 9)141))
Other 5(0%) 5(8%1
[ACC Vol. 17 . No. I
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Table 3. Electrophysiologic nariabtes in 101 Patients
All values are expressed in ms . None of the differences between the two
groups an, statisti®Ily significant . ante = antemgrade: ERP = effective
refractory period:relm = retrograde : Ill = reciprocating tachycardia ; SRR =
slnnen RR interval during atrial fibrillation . Other abbreviations as in Tables
1 and 2.
14% of patients of group I and in 12% of patients of group 2 . A
seplal pathway was present
in 10% and 14% of group I and 2,
respectively. Five patients (14%) in group I and six patients
(9%) in group 2 had multiple-sided accessory pathways.
Prediction of syncope by ekctrophysiolegk variables (Ta .
bk 4). There seems to be no elecrrophysiologic variable
enabling prediction eef syncope occurrence. In fact . the cycle
length of induced reciprocating tachycardia and the acces-
sory pathway refractoriness of %270 ms showed little spec-
ificity and sensitivity . Similarly, a minimal RR interval 5250
ms during atria) fibrillation could not account fur the syn-
cope
; sensitivity, specificity and positive and negative pre-
dictive values were comparable with those obtained from the
analysis of cycle length during C
.e tachycardia or antero-
grade accessory pathway refractoriness .
Prognostic salve of electrophysinlngie variables and syn-
cope (Table 5). There were 10 patients of group 1128%) and
12 patients of group 2 (18%) who had a history of aborted
Figure 1. Correlation analysis of heart rate (cycle length in ms)
during tachycardia induced dorms electrophysiologic study and
during ECU-documented spontaneous episodes .
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Figure 2
. Correlation analysis of meam heart role (cyck length in
ms) during atria) fibrillation induced during etectrophysielogie study
and during KG-documented-pontanecus episodes .
sudden death . A shortest RR interval during induced lariat
fibrillation of x250 ms was present in 20 of these 22 patients
with a history of cardiac arrest
. Furthermore. 17 of the group
who experienced aborted sudden death showed an antero-
grade refractory period of the accessory pathway of <270 ms
in the electrophysiologic study
. However, one patient who
presented with cardiac arrest was
excluded because it was
not possible to determine exactly the aaterograde effective
refractory period of his accessory pathway .
There was no correlation between syncopal episodes and
very rapid ventricular rates occurring during atria! fibrilla-
tion- In fact, syncope was a less sensitive and specific
marker for recognition of a dangerous rapid ventricular rate
(Table
5) ;
only 10 patients with a syncopal episode had a
history of life-threatening rapid ventricular rates during atrial
fibrillation.
The symptom of"syncope :' in combination with the two
accepted risk markers far sudden death in Wolf Parkinson-
White syndrome patients, failed to improve the prognostic
value of these two markers. In fact, only 8 of the 22 patients
with cardiac arrest had both a syncopal episode and a
_! ortest RR interval during axial
fibrillation of x250 ms and
Figure 3. Shortest RR intersal between two maximally pre-excited
QRS ccmplexes during atria) fibrillation in the clinically documented
arrhythmia in relation to the data during elecuophysiologic study .
Group 1
, . - 36)
Group 2
(n - 65)
PA interval
33 *- 9 32 - 7
AH interval 92 - 33 91 - 40
ERP. right atrium 241 = 33 231 a 40
ERP, AV nude, arse 269% 51 246 x 43
ERP, AV ∎ode, ren0 247 = 38 250 = 51
ERP, essasmry pafiwny, none
L2 s 56 246 = 54
ERP. accessory ps=hway . 78110 227 m 30
246 . 42
Right venvil, -"-0 ± 31 230 '_ 34
ERP-AP 1270no 24167%) 40162%)
Inducedarrhythmies
Cycle length RT 326 - 58 333
. 46
Average RR interval during A fib
347 0 48 366 t 43
Minimum RR interval during A fib 249 x 48 246 c 43
SRR-A fib s250 ma 27(75%) 430,01
Abbreviations as in Tables I la y.
phhreclalmm. a,
w
Tahkc, I m I .
only!) patients presented both with syncope and a refractory
period of accessory pathway of < 2?0 ms (Table J)_
Discussion
Prognwlic role of syMpe. Natural history studies (I)
suggest that many patients with Wolff-Parkinson-White svn-
drome are asymptomntic or largely symptom free . A syncu-
pal or near syncopal episode is a less-common event in these
patients . The uccurrencc of this symptom suggests The
possibility of very rapia reciprocating tachycardia or atrial
tibrillaliun with a lipid ventricular response due In anomo-
lous conduction . 1n this case the syncope could be regarded
as a warning event heralding the future development of
sudden cardiac death . Because of the potential risk of
sudden death in patients with an accessory pathway capable
of a sustaining rapid ventricular rate during atrial fibrillation .
syncope might be a marker of this high-risk patient sub-
group . In that event individuals with a history of syncope
warrant complete electrophysiologic testing and aggressive
therapy as well .
However, in contras) to this opinion, our data show that
syncope is a more benign clinical symptom in patients with
Wolff-Parkinson-White syndrome, In fact, according to Yee
et al . (4) and Paul et al . (g) . who reported a syncope
incidence of 22% and 19%
. respectively, the symptom "syn-
cope" was a relatively common characteristic in the history
of our patients, present in 361A of our study population .
Consistent with the findings of Yee et al . 141, 311 patients of
this study with syncope had clinical characteristics, arrhyth-
mic events and considerable simllarities in heart late during
lachyarrhythmia episodes comparable with those not report .
lug syncope .
Table 5. Prediction of Sudden Dcalh by Syncope and Elecrraphysialogc Variables
Prediction of syncope occurrence by eleclrophysiologic
study. Assuming that a relation exists between syncope and
episodes of tacbyarrhythmias in Wolff-Parkinson-White pa .
tients, a particular etectrophysiologic pattern might he ex-
pected . However . no patient of our study population showed
abnormal inlraalrial or airiovenlricular electrophysialogic
variables and, significantly, exceptional rapid anterugrade
conduction over the accessory pathway was nut found. In
addition, there was considerable agreement in mean heart
rate during reciprocating tachycardia nr'trial fibrillation
between the patients' inherent lachycarnlia and those in-
duced during electrophysiologic study . The good relntion
between clinical arrhythmia characteristics and electraphys-
iologic findings in our patients is in agreement with Rinne et
al . (16). These similarities suggest that tachyarrhythmias are
probably not the cause of syncope
. This is partially sup-
ported by our findings that eight patients of this study who
had experienced syncope showed electrophysiologic varia-
bles similar to those recorded at the time of their syncopal
event
.
Therefore, these data suggest the "primum movens" of
syncope occurring in Wolf-Parkinson-White patients to be
classified as unclear. We consider it important that many
patients in our study were able to sustain rapid ventricular
rates during atrial fibrillation or fast reciprocating tachycar-
din and yet were not subject to syncope . On the other hand,
a similar percentage of patients with and without syncope
showed a shortest interval of preexciled beats during aerial
fibrillation of-<25(1 ms or an anterograde refractory period of
the accessory pathway of <279 ms . Although our and Yee's
141 data arc- in disagreement with the report of Paul el al . (8)
who were able to demonstrate a strong relation and predict-
ability of syncope and the shortest RR interval during Alrial
se, miry
SJ I
Speoifiupn
f'+I
Pasau's-
Predictive Noun
nit
ts'egati.c
3edicrive Value
iwl
Syncanc 75 67 38 67
SRR4 11, -111- 91 '6 z9 93
SNR-Alit, -2511ms1sNOaot :I. 141 t6 31
ERP-AP ,27oms ei JI xd
ERP-.OP cto ms . syncope 43 79 39
C
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Tal4r 4 . I'lrdictian of Syncuac by Eledrophysiolegi_ Vatia*les
P-ui,Netwliv
Semhicil5 Syvoidly Pedictivc Value
Predctve Vator
r81 1°cal PAI 1`kl
L rcir Ici''t , R"I' <}Ix1 ms 6x St Si
can-_'a 71 31 30
l0
e'i -AP -7711 vs
77 37 i6
JOCC r
ut . I
L
Na I
Januurv l'HI :J,'r
fibrillation, it must be noted thaw they studied a younger
patient poptualion and, in addition . selected a lower value of
the RR interval Is220 ms) during atrial fibrillation .
Predictive value of electrophysiolttgic brunt for the risk of
sudden death
. There is general agreement in considering the
shortest RR interval between two consecutive pre-excited
complexes daring atrial fibrillation and the anterograde
effective refractory period of accessory pathway as high-risk
markers 19-11 .17). Although accessory pathway refractori-
ness tends to correlate with the shortest RR interval 1171 . the
effective refractory period cannot always be measured and
other variables, such as heart rate. may also affect the
refractoriness 1171 . Therefore, the accessory pathway refrac-
toriness lacks sensitivity and is less predictive than the
shortest RR interval during atrial fibrillation (101
: in this
respect, our data confirm previous reports I10-12) on the
superiority of the shortest Rk interval between two consse-
utive pre-excited beats during atria[ fibrillation of <_250 ms as
a better predictor of risk of sudden death than the antere-
grade effective refractory period of accessory pathway of
<270 ms
.
Prediction of sudden death by syncope
. The data of this
study support the hypothesis that the clinical finding of
"syncope" has a poor predictive accuracy for identifying
patients with Wetff-Parkinson-White syndrome who are a1
risk for sudden death, One reason for this is suggested by
Bayesian analysis and relates to the relatively low incidence
of sudden death in patients with Wolff-Parkinson-While
syndrome . Nevertheless, because syncope has been re
Sanded as an alarming event in such patients, a higher
sensitivity of this event in respect to sudden death should he
expected than we actually found, The failure of the symptom
"syncope" to be a marker for risk of sudden death i,
evidence by its comparison with other risk markers . i n
particular, the shortest RR interval during atrial fibrillation .
In fact. using "syncope" in combination with the other two
risk markers examined improves the specificity of the lest,
demdnstreuag that patients with a long RR interval during
atrial fibrillation (>250 ms) or with an anterograde effective
refractory period X270 ms . or both, hot without experienc-
ing syncope have a better prognosis .
The potential reason for this failure of syncope to predict
sudden death may lie in the indistinguishobility of patients
who really experienced unconsciousness because of rapid
conduction through the accessory pathway from other pa.
bents in whom the cause of syncope could be related to
extracardiac mechanisms . Furthermore. other speculative
mechaeismsofsyncope in Wolff-Parkinson-While syndrome
patients could be related to abnormal catechelamine re-
sponse and activation of cardiac vagal a fferents . a
s recently
suggested by .Alquist et al
. (18) or to mechanical activation
either by cardiac distension and stretching or by vigorous .
forceful and rapid systolic contraction generating "ventric-
ular syncope : ' as discussed by Ahboud 1 i9y resulting both in
marked vasodilatation and hradycardia .
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Limitation of study
. A retrospective study is always
subject to several limitations because of lack of collected
data; in this way. this study cannot cover the role of
psychologic, metabolic and, autonomic factors active at the
time of syncope occurrence
. Furthermore, absence of a
statistically significant difference between the two patient
groups could he related to the sample size hype 2 error). Our
relatively high incidence of syncope (36s7c) compared with
the 2'_c and 1970 incidence previously reported
(4.8) could
be attributed to different selection criteria or to a preselected
patient population referred to our institution especially for
surgical treatment of Wolff-Parkinson-White syndrome .
However, even considering the syncope group alone, these
patients do not present more risk features than other symp-
tomatic patients with WolffParkinson-White syndrome re-
ferred for electrophysiologic study .
Another possible limitation of this study ensues from the
patient's supine position during the electrophysiologic study
that could drastically mask the hemodynamic mechanism of
failure to compensate for the sudden rate increase during
tachy . arrhythmia
. In fact, previous studies (20) reported
complex adjustments in contractility, vascular resistance,
stroke volume and atrioventricular timing during tachycar-
dio- the interrelation of which is still poorly understood, and
one or more of these factors could contribute to impair the
patient's hemodynamic state . Although it would be worth-
while to evaluate the symptom of - 'syncope" in a control
study population of normal subjects, this is not easy to do
because the majority of subjects with syncope seem to have
some form of organic heart disease .
Conclusions . The results of this study suggest that syn-
cope is a relatively common feature in pntients with Wolff-
Parkinson-White syndrome referred for clectrophyslologic
testing
: its occurrence alone fails to correctly identify pa
tients at risk of sudden death
. The main cause of syncope
occurring in patients with WnlffParkinson-While syndrome
remains obscure and further studies are needed to elucidate
the mechanism of such events . Furthermore, the absence of
clinical relevance of syncope in these patients and the
inability to improve the risk stratification by eteclrophysio-
logic variables suggest a more restrictive management in
patients with Wolff-Parkinson-White syndrome and syn-
cope . The decision to proceed with invasive clectrophysio-
logic evaluation or aggressive treatment . or both, of patients
with Waltl-Parkinson-White syndrome should be based on
other clinical and electrophysiologic findings instead of
emphasizing the occurrence of syncope .
tvv shank
Sir .. Inge Habel for her expert help in preparing this manuscript .
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